PAM
OCRX

Panagora Asset Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Panagora Asset Management’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-41,298
Closed -$47K – 2413
2017
Q3 		$47K Sell
41,298
-8,857
-18% -$9.5K ﹤0.01% 2066
2017
Q2 		$58K Hold
50,155
– – ﹤0.01% 2030
2017
Q1 		$66K Buy
50,155
+41,256
+464% +$52.5K ﹤0.01% 1956
2016
Q4 		$19K Hold
8,899
– – ﹤0.01% 2233
2016
Q3 		$24K Buy
+8,899
New +$22.2K ﹤0.01% 2241

Panagora Asset Management's OCRX Position: Q4 2017 in Review

Panagora Asset Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 41,298 shares — an estimated $47K sold.

Panagora Asset Management first reported a position in OCRX in Q3 2016 and held it in 5 quarters. The position peaked at $66K in Q1 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • Panagora Asset Management reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Panagora Asset Management sold 41,298 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $47K.
  • Panagora Asset Management first reported a position in Ocera Therapeutics, Inc. in Q3 2016 and held it in 5 quarters.
  • Panagora Asset Management's Ocera Therapeutics, Inc. position peaked at $66K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.